Year: 2012
Type: book
Abstract: Childhood Obesity 4 earliest event in this chain of morbidity, the deregulation of glycemic homeostasis is probably the most important mediator between overweight and death.Nevertheless, a significant proportion of obese individuals may attain longevity without the previously mentioned comorbidities.This is due to the fact that the determinant of individual metabolic risk associated with accumulation of adipose tissue (AT) is not represented by its excess only, but above all, by its distribution, which can be determined by means of simple and available techniques such as WC measurement, as previously mentioned.AT is recognized as the largest energy store of free fatty acids (FFA) and triglycerides (TG), and more recently as an endocrine organ that regulates the secretion of adipokines, which coordinate energy metabolism, insulin sensitivity and feeding behavior, not only in adults but also in pediatric populations.Imbalance between visceral and subcutaneous AT is capable of altering its physiology.In obese individuals, especially those with abdominal obesity, there is an increase of cytokines, such as interleukins (IL), tumor necrosis factoralpha (TNF-α), c-reactive protein (CRP), plasminogen activator inhibitor (PAI-1) and fibrinogen among others, known for their proinflammatory, prothrombotic and proatherogenic actions, and a decrease in a cytokine with opposite characteristics, called adiponectin.In addition, the adipocytes that constitute visceral AT present intense lipolytic activity and when in excess, promote an increase of FFA circulanting levels that contribute to the presence of ectopic fat deposition.These two basic mechanisms (imbalance in cytokine production and increase in FFA) favor both fat deposition in non habitual sites essential to the maintenance of glucose homeostasis, such as pancreas, liver and muscle, among others.This may lead to the development of insulin resistance (IR) and states of chronic inflammation with significant impact on carbohydrate metabolism and vascular system, promoting endothelial dysfunction.The inflammatory state is recognized by the increase in some cytokines (CRP, IL-6, TNF-α, etc) and is a great predictor of CVD.Therefore, it is rational to include CRP, especially highsensitivity CRP (hs-CRP), in screening for the risk of CVD, also in the pediatric population at risk of these diseases.Fatty liver deposition or hepatic steatosis (HS) is considered a hepatic component of the metabolic syndrome (MS) by the International Diabetes Federation (IDF), and in adult population it is an established predictor of dysglycemia and DM2.In youth, an association between obesity, particularly abdominal obesity and HS has been confirmed.Furthermore, the degree of steatosis in the liver has a decisive influence on the development of alterations in glycidic metabolism, with an important increase in hepatic glucose production, due to increase in gluconeogenesis.It is thus imperative to conduct studies on ectopic fat deposits in youths with excessive weight in order to diagnose individuals with this alteration and calculate a risk score for CVD and DM.This screening may be done by means of simple techniques such as hepatic enzyme measurements (aspartate aminotransferase [AST], alanine aminotransferase [ALT] and hepatic ultrasound and/or sophisticated techniques (not always available in developing countries) such as nuclear magnetic resonance (NMR) with spectroscopy or hepatic biopsy, which is an invasive method, especially for children.Research in intramyocellular fat using NMR is also fundamental for determining peripheral muscle insulin sensitivity however the technique is not available for clinical use.Epidemiological and Clinical Aspects in a Developing Country 5 2.1 Cardiovascular system Cardiovascular screening is normally recommended for adults, especially those with a family history positive for CVD.Nevertheless the combination of atherogenic diet, sedentary lifestyle and genetic have resulted in overweight and atherogenic dyslipidemia (decrease in high-density-lipoprotein cholesterol [HDL-C], increase in low-densitylipoprotein cholesterol [LDL-C] and TG at very early stages of life, thus anticipating the need for screening the cardiovascular system.Although the vascular pathology in children with obesity and DM has been described, the course of development of these abnormalities has not yet been fully explained.In adults, abnormalities in vascular function precede the development of the anatomic or structural pathology.Vascular dysfunction, including reduction in endothelial function and vascular complacency and increase in inflammatory markers are therefore the initial findings in subjects with obesity, dyslipidemia, AH and carbohydrate metabolism disorders.Inflammation and maintenance of these risk factors subsequently lead to the development of atherosclerosis with alteration in vascular structure and increase in its rigidity. Mechanism of atherogenesisWhen elevated, LDL-C infiltrates the arterial endothelium, producing fat striae, even at very early ages in life (1st and 2nd decades) and if dyslipidemia persists, various subtypes of white globules, similar in shape, infiltrate the vascular wall and secrete inflammatory cytokines and oxidative molecules, with development of an inflammatory state and oxidative stress (OS).OS, defined as imbalance between the concentrations of reactive oxygen species (ROS), such as superoxide and antioxidants (superoxide dismutase and catalase, among others), are essential for the development of endothelial damage, representing the initial and fundamental stage that is interposed between the formation of atherosclerotic plaque and the thrombus.Signaling pathways that regulate cytokine expression, such as the nuclear factor kappa B transcriptional pathway (NF-kB), is also activated by OS, resulting in the induction of adhesion molecule expression and inflammation on the vascular wall, contributing to the atherogenic process.In association, the clotting cascade and platelet aggregation are activated in an effort to repair the atheromatous lesion.This process can induce occlusive thrombi, infarctions and generalized micro and macro-vascular disease.Some systemic markers that represent OS have been identified in youngsters, confirming early onset of the atherosclerotic process.In various studies, including our study in adolescents, inflammation markers, such as the simple overall leukocyte count and high-sensitivity CRP (hs-CRP) have been shown to be elevated in this group with clear demonstration of the relationship between inflammation and obesity, MS and a number of its components.The clinical usefulness of monitoring these markers in the pediatric population has not been well studied, nevertheless, some authors recommend that it should be measured, based on the hypothesis that the subclinical inflammation present in MS results from a silent and progressive atherosclerotic process that started in the first decade of life that could be stopped or at least delayed if identified.In addition, thrombosis markers, such as fibrinogen, IL (6,8, 1 B), TNF-α, monocyte chemotactic protein-1 (MCP-1) and PAI-1 have elevated levels in obese youngsters with MS.Up until very recently, only necropsy studies warned about the beginning of atherogenesis early in life, and non invasive techniques have attested to this sequence of events.As a consequence of this abdominal obesity-IR binomial, a systemic inflammatory state is produced, which functions as a trigger for the atherogenic process.The earlier the onset of overweight, the more prematurely this will manifest clinically.Therefore, in order to implement primary prevention of CMD, investigation/prevention/treatment of risk factors, such as obesity, dyslipidemia, AH and disturbances in carbohydrate metabolism and its consequences must begin in the initial stages of life.
Author: Ari Yuca, Sevil
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: childhood obesity, abdominal obesity, visceral adipose tissue, adipokines, insulin resistance, chronic inflammation, high-sensitivity C-reactive protein, cardiovascular risk, hepatic steatosis, metabolic syndrome, dyslipidemia, dyslipoproteinemia, dysglycemia, type 2 diabetes, endothelial dysfunction, adipocyte lipolysis, free fatty acids, ectopic fat deposition
Open Access status: green
OpenAlex ID: W7208125945
